Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein

Virus Research

Volumn 97, Issue 2, 2003, Pages 103-110

  Ruggieri, A ^a   Murdolo, M ^a   Rapicetta, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Core; FasL; HCV; HepG2

Indexed keywords

CORE PROTEIN; FAS LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COCULTURE; DNA VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE; TARGET CELL;

HEPATITIS C VIRUS;

EID: 0242361245     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2003.08.004     Document Type: Article

References (56)

1. Aoki Y., Aizaki H., Shimoike T., Tani H., Ishii K., Saito I., Matsuura Y., Miyamura T. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase. Virology. 250(1):1998;140-150.
2. Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol. 74:2000;1736-1741.
3. Bauer M.K., Vogt M., Los M., Siegel J., Wesselborg S., Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273(14):1998;8048-8055.
4. Bergqvist A., Rice C.M. Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J. Virol. 75:2001;772-781.
5. Chang S.H., Young G.C., Beom-Sik K., Isabel M., Lester I.M., Young S.H. The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology. 276:2000;127-137.
6. Chen X., Zachar V., Chang C., Ebbesen P., Liu X. Differential expression of Nur77 family members in human T-lymphotropic virus type1-infected cells: transactivation of the TR3/nur77gene by Tax protein. J. Virol. 72:1998;6902-6906.
7. Chiou S.H., Liu J.H., Hsu W.M., Chen S.S.-L., Chang S.-Y., Juan L.-J., Lin J.-C., Yang Y.-T., Wong W.-W., Liu C.-Y., Lin Y.-S., Liu W.-T., Wu C.-W. Up-regulation of fas ligand expression by human cytomegalovirus immediate-early gene product. 2. A novel mechanism in cytomegalovirus-induced apoptosis in human retina. J. Immunol. 167(7):2001;4098-4103.
8. Depraetere V., Golstein P. Fas and other cell death signaling pathways. Semin. Immunol. 9:1997;93.
9. Douglas R.G., Ferguson T.A. The role of Fas ligand in immune privilege. Nature. 2:2001;917-924.
10. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., Krammer P.H.et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1995;1223-1230.
11. Geissler M.K., Tokushige T., Wakita V.R., Zurawski J.R., Wands J.R. Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. Vaccine. 16:1998;857-867.
12. Hahn C.S., Cho Y.G., Kang B.-S., Lester I.M., Hahn Y.S. The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology. 276:2000;127-137.
13. Harada T., Kim D.W., Sagawa K., Suzuki T., Takahashi K., Saito I., Matsuura Y., Miyamura T. Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA. J. Gen. Virol. 76:1995;1215-1221.
14. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimothono K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5547-5551.
15. Hiramatsu N., Hayashi N., Katayama K.et al. Immunohistochemical detection of fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology. 19(6):1994;1354-1359.
16. Honda M., Kaneko S., Shimazaki T., Matsushita E., Kobayashi K., Ping L.-H., Zhang H.-C., Lemon S.M. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology. 31:2000;1351-1359.
17. Houghton, M., 1996. Hepatitis C viruses. In: Fields, B.N., Knope, D.M., Howley, P.M. (Eds.), Virology, third ed., vol. 1. Lippincott and Raven, Philadelphia, pp. 1035-1058.
18. Jin D.-Y., Wang H.-L., Zhou Y., Chun A.C.S., Kibler K.V., Hou Y.-D., Kung H.-F., Jeang K.-T. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transormation. EMBO. J. 19:2000;729-740.
19. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:1994;528-530.
20. Kittlesen D.J., Chianese-Bullok K.A., Yao Z.Q., Braciale T.J., Hahn Y.S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106:2000;1239-1249.
21. Kondo T., Suda T., Fukuyama H., Adachi M., Nagata S. Essential role of the Fas ligand in the development of hepatitis. Nat. Med. 3:1997;409-413.
22. Lacanà E., D'Adamio L. Regulation of Fas ligand expression and cell death by apoptosis-linked gene 4. Nat. Med. 5:1999;542.
23. Lai, M.C., Ware, C.F., 1999. Hepatitis C virus core protein: possible roles in viral pathogenesis. In: Hegerdorn, C.H., Rice, C.M. (Eds.), The Hepatitis C Virus. Springer, Berlin, pp. 117-130.
24. Lee C.H., Choi Y.H., Yang S.-H., Lee C.W., Ha S.J., Sung Y.C. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology. 279:2001;271-279.
25. Lee M.-O., Kang H.-J., Cho H., Shin E.-C., Park J.H., Kim S.J. Hepatitis B virus X protein induced expression of the Nur77 gene. Biochem. Biophys. Res. Commun. 288:2001;1162-1168.
26. Lee S.H., Shin M.S., Lee H.S., Bae J.H., Lee H.K., Kim H.S., Kim S.Y., Jang J.J., Joo M., Kang Y.K., Park W.S., Park J.Y., Oh R.R., Han S.Y., Lee J.H., Kim S.H., Lee J.Y., Yoo N.J. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum. Pathol. 32(3):2001c;250-256.
27. Liu Z.X., Govindarajan S., Okamoto S., Dennert G. Fas-mediated apoptosis causes elimination of virus specific cytotoxic T cells in the virus-infected liver. J. Immunol. 166:2001;3035-3041.
28. Li-Weber L., Laur O., Dern K., Krammer P.H. T cell activation-induced and Hiv tat-enhanced CD95 (APO-1/Fas) ligand transcription involves NFkB. Eur. J. Immunol. 30(2):2000;661-670.
29. Luo K.X., Zhu Y.F., Zhang L.X., He H.T., Wang X.S., Zhang L. In situ investigation of fas/FasL expression in chronic hepatitis B infection and related liver disease. J. Viral Hepat. 4:1997;303-307.
30. Marusawa H., Hijikata M., Chiba T., Shomotohno K. Hepatitis C virus core protein inhibits Fas- and tumour necrosis factor alpha-mediated apoptosis via NF-κB activation. J. Virol. 73:1999;4713-4720.
31. Matsumoto M., Hsieh T.-Y., Zhu N., VanArsdale T., Hwang S.B., Jeng K.-S., Gorbalenya A.E., Lo S.-Y., Ou J.-S., Ware C.F., Lai M.M.C. Hepatitis C virus core protein interacts with cytoplasmic tail of lymphotoxin-β receptor. J. Virol. 71:1997;1301-1309.
32. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepat. 7:2000;2-14.
33. + T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylyc acid. Immunology. 87:1996;581-585.
34. Nagao M., Nakajima Y., Hisanaga M., Kayagaki N., Kanehirom H., Aomatsum Y., Ko S., Yagita H., Yamadam T., Okumuram K., Nakano H. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo. Hepatology. 30:1999;413-421.
35. Nagata S. Fas Ligand and immune evasion. Nat. Med. 2(12):1996;1306-1307.
36. Ogasawara J., Watenabe-Fukunagam R., Adachi M.et al. Lethal effect of the anti-Fas antibody in mice. Nature. 364:1993;806-809.
37. Owen-Schaub L., Chanm H., Cusak J.C., Roth J., Hill L.L. Fas and Fas ligand interactions in malignant disease. Int. J. Oncol. 17:2000;5-12. (Review).
38. Pinkoski M.J., Brunner T., Green D.R., Lin T. Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278:2000;G354-G366.
39. Ray R.B., Ray R. Hepatitis C virus core protein: intrigring properties and functional relevance. FEMS Microbiol. Lett. 202(2):2001;146-156.
40. Ray R.B., Lagging L.M., Meyer K., Steele R., Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:1995;209-220.
41. Ray R.B., Meyer K., Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology. 226:1996;176-182.
42. Ray R.B., Steele R., Meyer K., Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:1997;10983-10986.
43. Ray R.B., Meyer K., Steele R., Shrivastava A., Aggarwal B.B., Ray R. Inhibition of tumour necrosis factor (TNF-α) mediated apoptois by hepatitis C virus core protein. J. Biol. Chem. 273:1998;2256-2259.
44. Ray R.B., Meyer K., Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology. 271:2000;197-204.
45. Ruggirei A., Harada T., Matsuura Y., Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology. 229:1997;68-76.
46. Ruggirei, A., Murdolo, M., Harada, M., Miyamura, T., Rapicetta M. Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing hepatitis C virus core protein. Arch. Virol., in press.
47. Shimoike T., Mimori S., Tani H., Matsuura Y., Miyamura T. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J. Virol. 73:1999;9718-9725.
48. Shin E.C., Shin J.S., Park J.H., Kim H., Kim S.J. Expression of Fas-related genes in human hepatocellular carcinomas. Cancer Lett. 99:1998;155-162.
49. Shin E.-C., Shin J.S., Park J.H., Kim H., Kim S.J. Expression of Fas ligand in human hepatoma cell lines: role of hepatitis B virus X (HBX) in induction of Fas ligand. Int. J. Cancer. 82:1999;587-591.
50. Soguero C., Joo M., Chianese-Bullok K.A., Nguyen D.T., Tung K., hahn Y.S. J. Virol. 76:2002;9345-9354.
51. Strand S., Hofmann W.J., Hug H., Muller M., Otto G., Strand D., Mariani S.M., Stremmel W., Krammer P.H., Galle P.R. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas)-ligand expressing tumour cells - a mechanism of immune evasion. Nat. Med. 2:1996;1361-1366.
52. Taya N., Torimoto Y., Shindo M., Hirai K., Hasebe C., Kohgo Y. Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br. J. Haematol. 110:2000;89-97.
53. Weith F., Ryseck R.P., Chen L., Bravo L. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5533.
54. Xu X.N., Screaton G.R., Gotch F.M., Dong T., Tan R., Almond N., Walker B., Stebbing R., Kent K., Nagata S. Evasion of cytotoxic T lymphocyte (CTL) response by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186:1997;7-16.
55. Xu X.-N., Laffert B., Sceaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A., Baur A. Induction of Fas ligand expression by HIV involves the interaction of nef with the T cell receptor ζ chain. J. Exp. Med. 189(9):1999;1489-1496.
56. Zhu N., Khosnan A., Schneider R., Matsumoto M., Dennert G., Ware C., Lai M.M.C. Hepatitis C virus core protein binds to the cytoplasmic domain of tumour necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72:1998;3691-3697.